Close Window

Digital Look Email A Friend

Venn Life Sciences shares drop despite revenue rise

Published by Josh White on 28th September 2016

(ShareCast News) - Drug development services and clinical trial management provider Venn Life Sciences announced its unaudited interim results for the six months to 30 June on Wednesday, with revenue of €9.06m, up from €4.25m in the first half of last year.

URL: http://www.digitallook.com/dl/news/story/25014054/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.